Clinical Drug Experience Knowledgebase

alanine

atezolizumab (Tecentriq)

axitinib (inlyta)

bevacizumab (avastin)

carboplatin (paraplatin)

cyclophosphamide (cytoxan)

dactinomycin (cosmegen)

docetaxel (taxotere)

doxorubicin (Doxil)

etoposide (vepesid)

everolimus (zortress)

fluorouracil (efudex)

girentuximab

hypericum perforatum

ifosfamide (ifex)

interferon alpha-2b (Intron-A)

isotretinoin (Accutane)

l-glutamine

manganese chloride

mannitol (Osmitrol)

medroxyprogesterone (provera)

pembrolizumab (keytruda)

sargramostim (leukine)

shark cartilage extract ae-941

sorafenib (nexavar)

sunitinib (sutent)

temsirolimus (torisel)

thalidomide (Thalomid)

vincristine (oncovin)

vitespen

volitinib

13c-pyruvate

7-hydroxystaurosporine

Activated CIK with CD3-MUC1

afatinib (gilotrif)

alisertib

allogeneic bone marrow

allogeneic hematopoietic stem cells (Hemacord)

allogeneic lymphocytes

allogeneic natural killer cells

allogeneic stem cells

allogeneic tumor cell vaccine

alvocidib

amifostine (ethyol)

aminocamptothecin

antineoplaston a10

anti-p53 t-cell receptor-transduced peripheral blood lymphocytes

Anti-thymocyte Globulin (Rabbit) (Thymoglobulin)

arsenic trioxide (trisenox)

atorvastatin (lipitor)

atrasentan hydrochloride

autologous dendritic cells

autologous hematopoietic stem cells

autologous lymphocytes

avelumab (bavencio)

azd-4547

azd-5672

b7-1

becatecarin

Belzutifan (Welireg)

binimetinib (mektovi)

bone autograft

bortezomib (velcade)

bryostatin

bupropion (wellbutrin)

busulfan (Myleran)

cabozantinib (cometriq)

calcium

capecitabine (xeloda)

capmatinib (Tabrecta)

carboxyamidotriazole

carfilzomib (kyprolis)

cimetidine (tagamet)

cisplatin (platinol)

crizotinib (xalkori)

cyclosporine (sandimmune)

dabrafenib (tafinlar)

dasatinib (sprycel)

defactinib

denileukin diftitox (ontak)

denosumab (prolia)

diphenhydramine (benadryl)

dolastatin

durvalumab (imfinzi)

epothilone

erlotinib (tarceva)

estramustine (emcyt)

ferumoxytol (feraheme)

fgf-5

Fluciclovine (Axumin)

fludarabine (fludara)

fludeoxyglucose f-18

gefitinib (iressa)

gemcitabine (gemzar)

gsk-2636771

guadecitabine

histamine

imatinib (gleevec)

indisulam

interferon alfa-1b (Rebif)

interferon gamma-1b (actimmune)

irinotecan (Camptosar)

ixazomib (ninlaro)

keyhole limpet hemocyanin

larotrectinib (vitrakvi)

lenalidomide (revlimid)

lenvatinib (lenvima)

melphalan (alkeran)

mk-1775

motexafin gadolinium

msk-2206

muromonab cd3 (Orthoclone OKT3)

mycophenolate (CellCept)

n-(4-hydroxyphenyl)all-trans retinamide

naltrexone (revia)

nelfinavir (viracept)

olaparib (lynparza)

oprelvekin (Neumega)

ortataxel

osimertinib (tagrisso)

paclitaxel (taxol)

palbociclib (ibrance)

pazopanib (votrient)

perifosine

peripheral blood lymphocytes

pertuzumab (perjeta)

phenylacetic acid (ucephan)

phenylacetylgluatmine

prednisone (meticorten)

recombinant adenoviral human p53 gene

romiplostim (nplate)

rpi.4610

sapanisertib

seribantumab

siltuximab (sylvant)

sitagliptin (januvia)

spartalizumab

stem cells

tacrolimus (prograf)

talabostat

tanespimycin

tariquidar

taselisib

technetium tc-99m sestamibi (Cardiolite)

thiotepa

topotecan (hycamtin)

toripalimab

trametinib (mekinist)

trastuzumab emtansine (kadcyla)

tretinoin (Retin-A)

triapine

tumour infiltrating lymphocytes

vandetanib (caprelsa)

vinblastine (velban)

vinflunine

vinorelbine (navelbine)

vismodegib (erivedge)

vm4-037

voriconazole (vfend)

water

zd6126

zinc dichloride

zoledronic acid (zometa)

124i-iodo-azomycin galacto-pyranoside

2g-1 tcr retroviral vector-transduced lyn

abt-751

ags-16m18

alpelisib (Piqray)

biomed 101

cbt-101

cd40 ligand

cetuximab (erbitux)

cngrc peptide-tnf alpha conjugate

custirsen

dacarbazine (dtic-dome)

denenicokin

exemestane (aromasin)

gem3psca

herv-e tcr transduced cd8+/cd34+ t cells in hlaa* 11:01 positive patients

human prostate-specific membrane antigen plasmid dna vaccine

hyperacute-renal cancer vaccine

il-4(38-37)-pe38kdel

il-7

interleukin-12

ixabepilone (ixempra)

mdx-1411

mesna (mesnex)

mogamulizumab (poteligeo)

mouse prostate-specific membrane antigen plasmid dna vaccine

mrx0518

mubritinib

neovax

nis793

o6-benzylguanine

orantinib

panitumumab (vectibix)

panobinostat (farydak)

(pg13-a(f/k-f-sgsg-t2a-b (opt) (2g-1 tcr) retroviral vector-transduced lymphocyte

pt2385

py314

qbs10072s

ro7198457

selumetinib (Koselugo)

seneca valley virus

sirolimus (rapamune)

stk1-ligand

tucotuzumab celmoleukin

vatalanib

y90 conjugated chimeric g250

AEterna Zentaris

Agenus Inc.

Aix-University of Marseille

AstraZeneca

Canadian Cancer Trials Group

Cancer and Leukemia Group B (CALGB)

Cancer Research UK

Central European Cooperative Oncology Group

Centre Leon Berard

Children's Cancer and Leukaemia Group

Cornell University

Department of Veteran Affairs

Eastern Cooperative Oncology Group

Erasmus University Rotterdam

European Organisation for Research and Treatment of Cancer

Fudan University

German Association of Urologic Oncology

Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany

Groupe D'Etude des Tumeurs Uro-Genitales

Harvard University

HonorHealth Research Institute

Huazhong University of Science and Technology

Hutchison MediPharma

Institut Gustave Roussy

Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd

Jiao Tong University

Katholieke Universiteit Leuven

Klinikum Nuernberg - Klinikum Nord

Loyola University

Lund University

Medical Research Council

Medical University of Vienna

National Institutes of Health (NIH)

New York University

Ningxia Medical University

Oregon Health and Science University

Oxford BioMedica

Pfizer

Radboud University

Royal Marsden Hospital NHS Trust

Saarland University

Scandinavian Sarcoma Group

SFJ Pharmaceuticals, Inc.

Societe Francaise Oncologie Pediatrique

Southwest Oncology Group

Spanish Oncology Genito-Urinary Group

State University of New York, Buffalo

Thomas Jefferson University

Universidad Autonoma de Barcelona

Universitaetsklinikum Schleswig-Holstein

University of Amsterdam

University of Calgary

University of California, Los Angeles

University of California, San Francisco

University of Glasgow

University of Leicester

University of London

University of Michigan

University of Montpellier

University of Oslo

University of Pennsylvania

University of Pittsburgh

University of Sheffield

University of South Florida

University of Western Australia

Vanderbilt University

Wake Forest University

Wilex

Actuate Therapeutics Inc.

Amgen

Apices Soluciones S.L.

Associació per a la Recerca Oncologica, Spain

Associacio Per la Recerca Oncológica

Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie (ARTIC)

Australian and New Zealand Urogenital and Prostate Cancer Trials Group

Barts & The London NHS Trust

Bayer

Baylor University

BeiGene

Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.

Big Ten Cancer Research Consortium

Brown University

Burzynski Research Institute

Caladrius Biosciences

Cancer Biotherapy Research Group

Cancer Immunotherapy Trials Network

Cancer Research Institute

Cancer Treatment Centers of America

Cardiff University

Cedars-Sinai Medical Center

Celgene

Celldex Therapeutics

Central European Society for Anticancer Drug Research (CESAR)

Centre Georges Francois Leclerc

City of Hope National Medical Center

Clinical Research Technology S.r.l.

Columbia University

Curie Institute

Cytokine Working Group

Dartmouth University

Developmental Therapeutics Consortium

Driven To Cure

Duke University

ECOG-ACRIN Cancer Research Group

Eisai

Eli Lilly

Emory University

Epizyme, Inc.

Exelixis

Fundacion Instituto Valenciano de Oncologia

Genentech

General Electric

Government of Russia

Gruppo Italiano Carcinoma Renale

Gruppo Oncologico Italiano di Ricerca Clinica

Guangzhou University

Hebrew University

Hellenic Cooperative Oncology Group

Herbert Irving Comprehensive Cancer Center

Hestia Duran i Reynals

Hoag Memorial Hospital Presbyterian

Hoosier Cancer Research Network

Hope Cancer Institute, Inc.

Hopital Saint Andre

Icahn School of Medicine at Mount Sinai

Idera

Indiana University

Inova Health System

Institut Paoli-Calmettes

Istituto Clinico Humanitas - Rozzano (MI), Italy

Istituto Nazionale per lo Studio e la Cura dei Tumori

Jinan University

Johns Hopkins University

Lantheus Medical Imaging

Leiden University

Loma Linda University

Ludwig Institute for Cancer Research

Mayo Clinic

McMaster University

Medical University of South Carolina

MedImmune

Memorial Sloan-Kettering Cancer Center

Merck

Mirati Therapeutics Inc.

National Heart, Lung, and Blood Institute (NHLBI)

Netherlands Working Group on Immunotherapy of Oncology

Nevada Cancer Institute

Newcastle University

Novartis

Ohio State University

Oncotech

Onyx

Ospedale Sacro Cuore

Peloton Therapeutics, Inc.

Pennsylvania State University

Pharmacyclics

Pierre Fabre

Pivotal S.L.

Prometheus Inc.

Providence Health & Services

Quercegen Pharmaceuticals

Russian Academy of Medical Sciences

Rutgers University

Sanofi

SCRI Development Innovations

Shenzhen BinDeBio Ltd.

Sichuan University

Sirna Therapeutics

Stanford University

Steba Biotech S.A.

St. Vincent Medical Center - Los Angeles

Sun Yat-Sen University

Syndax Pharmaceuticals

Temple University

The Angeles Clinic

The Christie NHS Foundation Trust

Theradex

The Royal Bournemouth Hospital

The University of Texas, Dallas

Threshold Pharmaceuticals

Tokyo Women's Medical University

Tulane University

UNICANCER

Universidad Complutense de Madrid

University of Athens

University of California, Berkeley

University of California, Davis

University of Chicago

University of Florida

University of Franche-Comté

University of Leeds

University of Maryland

University of Medicine and Dentistry of New Jersey

University of Milan

University of Minnesota

University of Nebraska

University of New Mexico

University of Nice Sophia Antipolis

University of Oklahoma

University of Oxford

University of Paris

University of Rochester

University of South Carolina

University of Southern California

University of Texas at Houston

University of Texas, San Antonio

University of Toulouse

University of Vermont

University of Versailles

University of Virginia

University of Washington

University of Western Ontario

University of Wisconsin

Utrecht University

Washington University in St. Louis

Wayne State University

West Virginia University

Yale University

Zhengzhou University

4DPharma PLC

Active Biotech AB

Agensys, Inc.

Apollomics, Inc.

Astellas

Biontech

British Columbia Cancer Agency

Cellex Patient Treatment GmbH

Clinical Study Support, Inc.

Cytheris

Doris Duke Charitable Foundation

Five Eleven Pharma, Inc.

Fiverings Co., Ltd.

GlaxoSmithKline

High Impact Clinical Research Support Program

Impact Biomedicines

Imperial College London

Institut fur Klinische Forschung, Germany

Johnson and Johnson

Julius-Maximilians University

Kyowa Hakko Kirin

Merck Serono

NanOlogy, LLC

NeoTX Therapeutics Ltd.

Neurocrine Biosciences

NewLink Genetics Inc

Northwestern University

Novotech

Oncovir, Inc.

Ono Pharmaceuticals

Osaka University

Peking University

Roche

Schering-Plough

Shanghai Junshi Bioscience Co.,Ltd.

Takeda

University of California, Irvine

University of Copenhagen

US Biotest

Virginia Commonwealth University

ZymoGenetics